The North America Viscosupplementation Market would witness market growth of 8.2% CAGR during the forecast period (2023-2030).
Viscosupplementation aims to improve the knee's functional status and reduce joint pain. Viscosupplementation demand is significantly fuelled by the rising prevalence of osteoarthritis (OA). The main factor causing persistent disability is osteoarthritis, a chronic degenerative joint disability. the market is expected to be driven by the rising demand for non-surgical osteoarthritis treatments, the prevalence of lifestyle-related conditions, and advances in the development of hyaluronic acid-based therapies.
According to the Government of Canada's statistical report, the Canadian population in July 2019 included 6,592,611 seniors. In July 2019, seniors represented 17.5% of the Canadian population. Due to the aging impact, which reduces the flexibility and strength of the cartilage, there is a considerable increase in the geriatric population, making them more vulnerable to knee and hip osteoarthritis. The senior population also exhibits a shift in the cells and extracellular matrix of joint tissues, intensifying the imbalance between anabolic and catabolic activity.
In 2020, 3.9 million adult Canadians above the age of 20 were estimated to have arthritis, according to Statistics Canada. Arthritis is more common in older people and more prevalent in women. Furthermore, North America's market has experienced tremendous growth due to the high awareness of these treatments and the high prevalence of arthritis joint pain among adults in the United States and Canada, along with other co-occurring conditions like diabetes. Hence, the region presents lucrative growth prospects for the market.
The US market dominated the North America Viscosupplementation Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,699.8 million by 2030. The Canada market is experiencing a CAGR of 10.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 9.6% during (2023 - 2030).
Based on Application, the market is segmented into Knee Osteoarthritis, Hand Osteoarthritis, Hip Osteoarthritis, and Others. Based on Product, the market is segmented into Three Injection, Single Injection, and Five Injection. Based on End-use, the market is segmented into Hospitals, and Orthopedic Clinics/ASCs. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Viscosupplementation Market is Projected to reach USD 8.2 Billion by 2030, at a CAGR of 8.6%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include DePuy Synthes (Johnson & Johnson), Sanofi S.A., Zimmer Biomet Holdings, Inc., Ferring Holdings SA, F. Hoffmann-La Roche Ltd., LG Chem Ltd. (LG Corporation), Anika Therapeutics, Inc., Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A), Smith & Nephew PLC and Seikagaku Corp.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Knee Osteoarthritis
- Hand Osteoarthritis
- Hip Osteoarthritis
- Others
By Product
- Three Injection
- Single Injection
- Five Injection
By End-use
- Hospitals
- Orthopedic Clinics/ASCs
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- DePuy Synthes (Johnson & Johnson)
- Sanofi S.A.
- Zimmer Biomet Holdings, Inc.
- Ferring Holdings SA
- F.Hoffmann-La Roche Ltd.
- LG Chem Ltd. (LG Corporation)
- Anika Therapeutics, Inc.
- Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
- Smith & Nephew PLC
- Seikagaku Corp.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Viscosupplementation Market, by Application
1.4.2 North America Viscosupplementation Market, by Product
1.4.3 North America Viscosupplementation Market, by End-use
1.4.4 North America Viscosupplementation Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. North America Viscosupplementation Market by Application
4.1 North America Knee Osteoarthritis Market by Country
4.2 North America Hand Osteoarthritis Market by Country
4.3 North America Hip Osteoarthritis Market by Country
4.4 North America Others Market by Country
Chapter 5. North America Viscosupplementation Market by Product
5.1 North America Three Injection Market by Country
5.2 North America Single Injection Market by Country
5.3 North America Five Injection Market by Country
Chapter 6. North America Viscosupplementation Market by End-use
6.1 North America Hospitals Market by Country
6.2 North America Orthopedic Clinics/ASCs Market by Country
Chapter 7. North America Viscosupplementation Market by Country
7.1 US Viscosupplementation Market
7.1.1 US Viscosupplementation Market by Application
7.1.2 US Viscosupplementation Market by Product
7.1.3 US Viscosupplementation Market by End-use
7.2 Canada Viscosupplementation Market
7.2.1 Canada Viscosupplementation Market by Application
7.2.2 Canada Viscosupplementation Market by Product
7.2.3 Canada Viscosupplementation Market by End-use
7.3 Mexico Viscosupplementation Market
7.3.1 Mexico Viscosupplementation Market by Application
7.3.2 Mexico Viscosupplementation Market by Product
7.3.3 Mexico Viscosupplementation Market by End-use
7.4 Rest of North America Viscosupplementation Market
7.4.1 Rest of North America Viscosupplementation Market by Application
7.4.2 Rest of North America Viscosupplementation Market by Product
7.4.3 Rest of North America Viscosupplementation Market by End-use
Chapter 8. Company Profiles
8.1 DePuy Synthes (Johnson & Johnson)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental & Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Sanofi S.A.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Zimmer Biomet Holdings, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Ferring Holdings SA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research and Development Expense
8.4.5 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 LG Chem Ltd. (LG Corporation)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 SWOT Analysis
8.7 Anika Therapeutics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Smith & Nephew PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional and Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Seikagaku Corp.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
TABLE 1 North America Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 2 North America Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 3 North America Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 4 North America Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 5 North America Knee Osteoarthritis Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Knee Osteoarthritis Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Hand Osteoarthritis Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Hand Osteoarthritis Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Hip Osteoarthritis Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Hip Osteoarthritis Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 14 North America Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 15 North America Three Injection Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Three Injection Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Single Injection Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Single Injection Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Five Injection Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Five Injection Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 22 North America Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 23 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Orthopedic Clinics/ASCs Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Orthopedic Clinics/ASCs Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Viscosupplementation Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Viscosupplementation Market by Country, 2023 - 2030, USD Million
TABLE 29 US Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 30 US Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 31 US Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 32 US Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 33 US Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 34 US Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 35 US Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 36 US Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 37 Canada Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 38 Canada Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 39 Canada Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 40 Canada Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 41 Canada Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 42 Canada Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 43 Canada Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 44 Canada Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 45 Mexico Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 46 Mexico Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 47 Mexico Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 48 Mexico Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 49 Mexico Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 50 Mexico Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 51 Mexico Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 52 Mexico Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 53 Rest of North America Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 54 Rest of North America Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 55 Rest of North America Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 56 Rest of North America Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 57 Rest of North America Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 58 Rest of North America Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 59 Rest of North America Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 60 Rest of North America Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 61 Key Information – DePuy Synthes
TABLE 62 Key Information – Sanofi S.A.
TABLE 63 key Information – Zimmer Biomet Holdings, Inc.
TABLE 64 key information – Ferring Holdings SA
TABLE 65 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 66 key information – LG Chem Ltd.
TABLE 67 Key Information – Anika Therapeutics, Inc.
TABLE 68 Key Information – Fidia Farmaceutici S.p.A.
TABLE 69 key Information – Smith & Nephew PLC
TABLE 70 Key Information – Seikagaku Corp.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Viscosupplementation Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Viscosupplementation Market
FIG 4 Porter’s Five Force Analysis: Viscosupplementation Market
FIG 5 North America Viscosupplementation Market share by Application, 2022
FIG 6 North America Viscosupplementation Market share by Application, 2030
FIG 7 North America Viscosupplementation Market by Application, 2019 - 2030, USD Million
FIG 8 North America Viscosupplementation Market share by Product, 2022
FIG 9 North America Viscosupplementation Market share by Product, 2030
FIG 10 North America Viscosupplementation Market by Product, 2019 - 2030, USD Million
FIG 11 North America Viscosupplementation Market share by End-use, 2022
FIG 12 North America Viscosupplementation Market share by End-use, 2030
FIG 13 North America Viscosupplementation Market by End-use, 2019 - 2030, USD Million
FIG 14 North America Viscosupplementation Market share by Country, 2022
FIG 15 North America Viscosupplementation Market share by Country, 2030
FIG 16 North America Viscosupplementation Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: DePuy Synthes
FIG 18 Swot Analysis: Sanofi S.A.
FIG 19 Swot Analysis: Zimmer Biomet Holdings, Inc.
FIG 20 Swot Analysis: Ferring Holdings SA
FIG 21 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 22 Swot Analysis: LG Chem Ltd.
FIG 23 Swot Analysis: ANIKA THERAPEUTICS, INC.
FIG 24 Swot Analysis: FIDIA FARMACEUTICI S.P.A.
FIG 25 SWOT Analysis: Smith & Nephew PLC
FIG 26 Swot Analysis: SEIKAGAKU CORP.